XBiotech Inc

XBIT

Get informed when a big investor buys or sells

Market Cap$69.51M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
XBiotech Inc	-1.5	-	-35%	-	-

$4.12

Current Fair Value

79% upside

Undervalued by 79% based on the discounted cash flow analysis.

Share Statistics

Market cap	$69.51 Million
Enterprise Value	$-38,183,973.00
Dividend Yield	$2.47 (-)
Earnings per Share	$-1.49
Beta	0.85
Outstanding Shares	30,487,731

Return

Return on Equity	-35.13%
Return on Assets	-33.77%
Return on Invested Capital	-35.81%

Valuation & Multiples

P/E Ratio	-1.54
PEG	-0.54
Price to Sales	-
Price to Book Ratio	0.58
Enterprise Value to Revenue	-
Enterprise Value to EBIT	0.82
Enterprise Value to Net Income	0
Total Debt to Enterprise	-0.05
Debt to Equity	0.01

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

August 13, 2026

EPS Estimate

$0.03

Average shareholder expectation

Revenue Estimate

$7.00 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.00000%
Total Calls	21,100▲ 14.67%
Total Puts	-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	6.54%▼ 0.99%
Total Invested	$4.68M▼ 14.62%
Investors Holding	38▼ 2.00%

ESG Score